Assistant Professor of Medicine, Northwestern University
Hematology
Dr. Lynne S. Kaminer, MD
|
|
Give Review
Lynne Kaminer is an expert in the field of Hematology. She studied medicine at Washington University School of Medicine in St. Louis. She has 4 awards "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Top MD" and "Super Doctor". Lynne Kaminer is a published MD. She published 25 publications, including: 'Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.' She accepts all Medicare patients.
Publications
- F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lym...
- Effect of an electronic health record on the culture of an outpatient medical oncology practice in a four-hospital integrated health care system: 5-year experience.
- Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation.
- Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin''s lymphoma.
- Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
- Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
- Oxaliplatin-related acute myelogenous leukemia.
- High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
- Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation.
- A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer.
- High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.
- Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
- Should the FDA mandate that autologous units drawn and transfused within a single institution be tested for markers of infectious disease?
- Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) wi...
- Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998).
- Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
- Variant translocations (9;11): identification of the critical genetic rearrangement.
- Molecular analysis of TCRB and ABL in a t(7;9)-containing cell line (SUP-T3) from a human T-cell leukemia.
- Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung.
- High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma.
- Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia.
- A phase I-II study of high-dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies.
- High-dose tri-alkylator chemotherapy with autologous stem cell rescue in patients with refractory malignancies.
- Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98).
Schools
Washington University In St Louis School Of Medicine
University Of Pennsylvania Hospital
University Of Chicago Hospitals
Procedures Preformed
- Bone Marrow Transplant
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- View All
Doctors Specialties
- Hematology
- Internal Medicine
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Top MD
- Super Doctor
Education
-
University of Chicago -
University of Pennsylvania Health System -
Washington University School of Medicine in St. Louis
Hospital
-
NorthShore University Health System -
NorthShore Skokie Hospital
Drug Facts
| NPI NUMBER | 1861423139 | |
| NPPES Provider LastName | KAMINER | |
| NPPES Provider FirstName | LYNNE | |
| NPPES Provider ZIPCode | 602011718 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 893.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 44.0 | |
| Percent Opioid Claims | 4.93 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861423139 |
| Last Name Of The Provider | KAMINER |
| First Name Of The Provider | LYNNE |
| View All |
Similar Doctors
|
Dr. Elaine L. Wade, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jennifer C. Obel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David L. Grinblatt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael A. Ellison, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. John H. Mitchell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neal S. Gold, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mary S. Shapiro, MD |
|
|
Dr. May Hashimi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alla Gimelfarb, MD
This Doctor is OpenDoctor Recommended.
|